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Abstract
Brain	mitochondrial	 dysfunction	 has	 been	 implicated	 in	 several	 neurodegenerative	
diseases.	The	distribution	and	efficiency	of	mitochondria	display	large	heterogeneity	
throughout	the	regions	of	the	brain.	This	may	imply	that	the	selective	regional	suscep‐
tibility	of	neurodegenerative	diseases	could	be	mediated	through	inherent	differences	
in	regional	mitochondrial	function.	To	investigate	regional	cerebral	mitochondrial	en‐
ergetics,	the	rates	of	oxygen	consumption	and	adenosine‐5′‐triphosphate	(ATP)	syn‐
thesis	were	 assessed	 in	 isolated	non‐synaptic	mitochondria	 of	 the	 cerebral	 cortex,	
hippocampus,	and	striatum	of	the	male	mouse	brain.	Oxygen	consumption	rates	were	
assessed	using	a	Seahorse	XFe96	analyzer	and	ATP	synthesis	rates	were	determined	
by	an	online	luciferin‐luciferase	coupled	luminescence	assay.	Complex	I‐	and	complex	
II‐driven	 respiration	 and	ATP	 synthesis,	were	 investigated	 by	 applying	 pyruvate	 in	
combination	 with	 malate,	 or	 succinate,	 as	 respiratory	 substrates,	 respectively.	
Hippocampal	mitochondria	exhibited	the	lowest	basal	and	adenosine‐5′‐diphosphate	
(ADP)‐stimulated	rate	of	oxygen	consumption	when	provided	pyruvate	and	malate.	
However,	hippocampal	mitochondria	also	exhibited	an	increased	proton	leak	and	an	
elevated	relative	rate	of	oxygen	consumption	in	response	to	the	uncoupler	carbonyl	
cyanide	 4‐(trifluoromethoxy)phenylhydrazone	 (FCCP),	 showing	 a	 large	 capacity	 for	
uncoupled	respiration	in	the	presence	of	pyruvate.	When	the	complex	II‐linked	sub‐
strate	succinate	was	provided,	striatal	mitochondria	exhibited	the	highest	respiration	
and	ATP	synthesis	rate,	whereas	hippocampal	mitochondria	had	the	lowest.	However,	
the	mitochondrial	efficiency,	determined	as	ATP	produced/O2 consumed, was similar 
between	the	three	regions.	This	study	reveals	inherent	differences	in	regional	mito‐
chondrial	energetics	and	may	serve	as	a	tool	for	further	investigations	of	regional	mi‐
tochondrial	function	in	relation	to	neurodegenerative	diseases.
K E Y W O R D S
brain	energy	metabolism,	cerebral	cortex,	hippocampus,	Seahorse	XFe96,	striatum
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1  | INTRODUC TION
The	mammalian	brain	is	a	complex	and	energy‐demanding	organ.	It	is	
estimated	that	70%–80%	of	the	total	energy	expenditure	of	the	brain	
is	accounted	for	by	processes	related	to	neuronal	signaling	(Attwell	
&	Laughlin,	2001;	Harris,	Jolivet,	&	Attwell,	2012).	This	means	that	a	
constant	production	of	energy	is	crucial	for	sustaining	cerebral	func‐
tion.	Mitochondria	are	cellular	structures	responsible	for	the	major‐
ity	of	energy	production	through	oxidative	phosphorylation,	which	
is	 the	 oxygen‐dependent	 production	 of	 adenosine‐5′‐triphosphate	
(ATP)	 (Figure	1a)	 (Nunnari	&	Suomalainen,	 2012).	 Inside	 the	mito‐
chondrial	matrix,	metabolic	substrates	are	oxidized	in	the	tricarbox‐
ylic	acid	(TCA)	cycle,	generating	energy	rich	electrons,	transported	
through	 the	 reduced	 carriers	NADH	 and	 FADH2.	 These	 electrons	
are	subsequently	transferred	through	the	electron	transport	chain	
(ETC),	consisting	of	distinct	protein	complexes	(I–IV),	to	generate	a	
proton	motive	 force	by	pumping	protons	out	of	 the	mitochondrial	
matrix,	which	drives	the	ATP	synthase	(also	known	as	complex	V)	to	
synthesize	ATP	(Papa,	Petruzzella,	&	Scacco,	2007).
A	growing	body	of	evidence	 suggests	 that	brain	mitochondrial	
dysfunction	 can	 mediate	 or	 accelerate	 the	 development	 of	 sev‐
eral	neurodegenerative	diseases	(Correia	et	al.,	2012;	Johri	&	Beal,	
2012;	Nunnari	&	Suomalainen,	2012;	Pathak,	Berthet,	&	Nakamura,	
2013).	The	brain	 consists	of	 several	well‐defined	areas,	 each	han‐
dling	different	cerebral	functions	and	with	distinct	susceptibility	to	
neurodegenerative	diseases	(Camandola	&	Mattson,	2017;	Masters	
et	 al.,	 2015;	 Poewe	 et	 al.,	 2017;	 Ross	&	 Tabrizi,	 2011).	 For	 exam‐
ple,	 Alzheimer’s	 disease	 primarily	 affects	 the	 cerebral	 cortex	 and	
hippocampus,	 whereas	 Huntington’s	 disease	 manifests	 predomi‐
nantly	 in	 the	striatum	 (Masters	et	al.,	2015;	Ross	&	Tabrizi,	2011).	
Furthermore,	mitochondria	found	throughout	the	different	brain	re‐
gions	and	cell	types	display	a	large	degree	of	heterogeneity	in	terms	
of	distribution	and	efficiency	(Dubinsky,	2009;	Sonnewald,	Hertz,	&	
Schousboe,	1998).	Collectively,	 these	observations	may	 imply	 that	
inherent	regional	differences	in	mitochondrial	function	could	be	the	
basis	of	regional	susceptibility	to	brain	diseases.	An	in‐depth	under‐
standing	of	regional	differences	in	mitochondrial	bioenergetics	may	
elucidate	possible	mechanisms	for	the	selective	neurodegeneration.
Cerebral	mitochondrial	function	can	be	investigated	using	sev‐
eral	 experimental	 approaches	 and	 a	 common	 preparation	 is	 iso‐
lated	mitochondria	 (Clark	&	Nicklas,	1970;	Lai,	Walsh,	Dennis,	&	
Clark,	1977).	The	use	of	isolated	mitochondria	allows	a	high	degree	
of	 control	 and	manipulation	 by	 circumventing	 cellular	 pathways.	
Previous	studies	have	primarily	been	performed	on	isolated	mito‐
chondria	from	the	rat	brain,	due	to	the	larger	amount	of	starting	
material	when	compared	to	mice	 (Clark	&	Nicklas,	1970;	Dagani,	
Marzatico,	&	Curti,	1988;	Lai	et	al.,	1977;	Sims,	1990).	However,	
recent	technological	advances	have	allowed	high‐throughput	mi‐
croplate‐based	 assessment	 of	 small	 quantities	 of	 mitochondria,	
making	 it	possible	to	run	several	conditions	 in	parallel	 (Barros	et	
al.,	2018;	Connolly	et	al.,	2018;	Rogers	et	al.,	2011;	Sauerbeck	et	
al.,	2011).	Here,	we	apply	two	such	assays	to	investigate	the	rate	
of	oxygen	consumption	and	importantly	link	this	to	the	rate	of	ATP	
production,	 in	 isolated	 non‐synaptic	mitochondria	 of	 the	mouse	
brain	from	three	areas	often	affected	by	neurodegeneration:	the	
cerebral	cortex,	hippocampus,	and	striatum.	In	addition,	using	two	
different	mitochondrial	fuels,	pyruvate	and	succinate,	we	dissect	
regional	mitochondrial	 function	mediated	through	complex	 I	and	
complex	II	of	the	ETC.
2  | METHODS
2.1 | Materials
Pyruvic	acid	 (107360),	 succinic	acid	 (S3674),	malic	acid	 (M1000),	
adenosine‐5′‐diphosphate	 (ADP,	 A5285),	 oligomycin	 A	 (75351),	
carbonyl	 cyanide	 4‐(trifluoromethoxy)phenylhydrazone	 (FCCP,	
C2920),	 antimycin	 A	 (A8674),	 and	 rotenone	 (R8875)	 were	 pur‐
chased	 from	 Sigma‐Aldrich	 (St.	 Louis,	 MO,	 USA).	 Percoll™	
(17‐0891‐01)	 was	 from	 GE	 Healthcare,	 Uppsala,	 Sweden.	
Luciferin‐luciferase	 (11‐501)	 was	 from	 BioThema	 AB	 (Handen,	
Sweden)	 and	 used	 according	 to	 the	manufacturer’s	 instructions.	
All	other	reagents	were	of	the	purest	grade	available	from	regular	
commercial sources.
2.2 | Animals
Six	male	NMRI	mice	 (Envigo,	Cambridgeshire,	United	Kingdom)	of	
12	weeks	 of	 age	 (weight:	 42.2	g	 ±	 3.4	g)	were	 housed	 in	 a	 patho‐
gen‐free,	 temperature	 and	 humidity‐controlled	 environment	 at	
the	Department	 of	Drug	Design	 and	 Pharmacology,	 University	 of	
Copenhagen.	The	mice	were	acclimatized	for	2	weeks	before	experi‐
ments	and	were	single‐housed	in	individually	ventilated	cages	with	
free	access	to	chow	and	water.	The	experiments	were	approved	by	
the	Danish	National	Ethics	Committee	and	performed	in	accordance	
with	 the	 European	 Convention	 (ETS	 123	 of	 1986).	 Mitochondrial	
function	is	affected	by	sex	steroids	(Gaignard	et	al.,	2017).	To	avoid	
introducing	 this	 potential	 confounding	 variation,	 all	 experiments	
were	performed	on	male	mice	and	hence	sex	specific	aspects	of	the	
work	could	not	be	evaluated.
Significance
Brain	mitochondrial	dysfunction	is	implicated	in	several	neu‐
rodegenerative	diseases	and	might	be	linked	to	inherent	re‐
gional	 differences	 in	 mitochondrial	 function.	 This	 study	
reports	several	differences	in	the	rates	of	oxygen	consump‐
tion	 and	 ATP	 synthesis	 of	 mitochondria	 isolated	 from	 the	
mouse	 cerebral	 cortex,	 hippocampus,	 and	 striatum.	 These	
findings	may	serve	as	a	foundation	for	further	investigations	
of	 the	 link	 between	 regional	 mitochondrial	 function	 and	
neurodegeneration.
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2.3 | Cerebral mitochondrial isolation
Isolation	of	non‐synaptic	mitochondria	from	the	cerebral	cortex,	hip‐
pocampus,	and	striatum	was	performed	as	described	in	Chinopoulos,	
Zhang,	Thomas,	Ten,	and	Starkov	(2011)	with	slight	modifications.	All	
procedures	were	performed	on	ice	or	at	4°C.	Mice	were	euthanized	
by	 cervical	 dislocation,	 decapitated	 and	 the	 brain	 quickly	 excised	
from	the	cranial	vault	onto	a	cooled	surface	covered	by	a	damp	fil‐
ter	paper.	The	brain	was	dissected	 into	 the	 three	distinct	 regions:	
cerebral	cortex,	hippocampus,	and	striatum	as	described	by	Spijker	
(2011).	Tissue	was	dissected	from	both	hemispheres	with	a	total	dis‐
section	time	of	approximately	3	min.	After	dissection,	the	tissue	was	
submerged	 in	 isolation	buffer	 (MSHE),	containing	 in	mM:	mannitol	
210,	sucrose	70,	HEPES	5,	EGTA	1	and	0.5%	BSA	(fatty	acid	free),	
pH	7.2,	and	gently	homogenized	using	a	Teflon	on	glass	douncer	at	
500	revolutions/min	 for	7–8	strokes.	The	homogenate	was	centri‐
fuged	(500	g	×	5	min)	to	pellet	cell	 remnants.	The	supernatant	was	
centrifuged	 (14.000	g	×	10	min)	 and	 the	 pellet	 re‐suspended	 in	
12%	Percoll	MSHE	solution.	This	suspension	was	gently	layered	on	
a	21%	Percoll	MSHE	solution	and	centrifuged	 (18.000	g	×	15	min).	
The	supernatant	was	discarded	and	the	pellet	was	washed	with	two	
subsequent	centrifugations	(18.000	g	×	5	min	and	14.000	g	×	5	min)	
by	suspending	the	pellet	in	MSHE	buffer	and	discarding	the	super‐
natant	 after	 each	 centrifugation.	 The	 final	 pellet,	 containing	 the	
isolated	mitochondria,	was	re‐suspended	and	diluted	in	MSHE	and	
protein	amounts	were	determined	using	the	Bradford	protein	assay	
with	BSA	as	standard	protein.
2.4 | Mitochondrial oxygen consumption—Seahorse 
XFe96 assay
The	oxygen	consumption	rate	(OCR)	of	regionally	isolated	mitochon‐
dria	 was	 investigated	 using	 a	 Seahorse	 XFe96	 analyzer	 (Seahorse	
Biosciences,	 MA,	 USA)	 (Iuso,	 Repp,	 Biagosch,	 Terrile,	 &	 Prokisch,	
2017;	Rogers	et	al.,	2011).	The	 isolated	mitochondria	were	diluted	
in	assay	buffer	(MAS),	containing	in	mM:	mannitol	220,	sucrose	70,	
KH2PO4	10,	MgCl2	5,	HEPES	2,	EGTA	1	and	0.2%	BSA	 (fatty	acid	
free),	pH	7.2.	25	µl	of	mitochondrial	suspension,	containing	2	µg	of	
protein	for	the	succinate	condition	and	4	µg	of	protein	for	the	pyru‐
vate/malate	condition,	were	added	to	a	Seahorse	96‐well	plate	and	
centrifuged	 (2000	g	×	20	min	×	4°C).	 After	 centrifugation,	 155	µl	
MAS	 containing	 pyruvate	 (10	mM)	 in	 combination	 with	 malate	
(2	mM)	or	succinate	(10	mM)	and	rotenone	(2	µM)	(all	final	concen‐
trations	and	pH	7.2),	were	added	and	the	wells	and	the	plate	was	an‐
alyzed	immediately	at	37°C.	Each	condition	was	performed	in	seven	
technical	replicates	for	each	mitochondrial	preparation.
The	applied	experimental	template	is	known	as	the	mitochondrial	
coupling	assay,	investigating	the	coupling	between	the	ETC	and	oxida‐
tive	phosphorylation	(Rogers	et	al.,	2011).	Each	experiment	consisted	
of	nine	measurements	cycles,	with	intermediate	injections	of	differ‐
ent	mitochondrial	modulators	 as	 depicted	 in	 Figure	1b.	 Each	mea‐
surement	cycle	lasted	3	min	and	was	followed	by	2	min	of	mixing	and	
1	min	of	rest.	Firstly,	three	baselines	measurements	were	performed	
before	addition	of	pharmacological	compounds.	After	injection	of	a	
compound,	1	min	of	mixing	was	performed	before	the	measurement	
cycle	was	initiated.	The	compounds	added	were	(all	in	final	concen‐
trations):	 ADP	 (4	mM),	 oligomycin	 A	 (2.5	µg/ml),	 FCCP	 (4	µM)	 and	
antimycin	A	(4	µM).	Firstly,	ADP	was	injected,	which	stimulates	ATP	
synthesis	and	thus	complex	V‐driven	respiration.	Subsequently,	oligo‐
mycin	A,	an	inhibitor	of	complex	V,	was	added	to	terminate	the	ADP‐
mediated	respiration.	The	uncoupler	FCCP	allows	protons	from	the	
intermembrane	space	to	flow	into	the	matrix	(Figure	1a),	stimulating	
uncoupled	respiration.	Finally,	antimycin	A	was	injected	to	inhibit	the	
flow	of	electrons	from	complex	III	to	complex	IV,	thus	leaving	only	re‐
sidual	non‐mitochondrial	oxygen	consumption,	which	was	measured	
for	three	measurement	cycles.	The	Seahorse	assay	works	by	forming	
a	transient	micro‐chamber	by	bringing	oxygen‐sensitive	probes	close	
to	the	mitochondria	in	the	wells.	Due	to	this,	concentrations	of	respi‐
ratory	substrates	and	mitochondrial	modulators	may	seem	high	when	
compared	to	other	mitochondrial	assays.	The	applied	amount	of	mi‐
tochondria,	 concentrations	 of	 respiratory	 substrates,	 and	 injected	
compounds	(saturating	concentrations)	were	all	verified	as	optimal	in	
our	setup.	It	was	assured	that	O2	was	not	depleted	during	the	mea‐
surement	period	and	that	the	O2	levels	reached	baseline	values	be‐
fore	the	next	measurement	cycle.	Data	were	collected	and	extracted	
using	the	Wave	software	(Agilent	Technologies,	CA,	USA).
Absolute	OCR	is	presented	as	pmol	O2	consumed/min/µg	pro‐
tein.	From	the	Seahorse	experiments	nine	data	points	were	obtained,	
denoted	(1)–(9)	(Figure	1b).	Before	data	analyses,	non‐mitochondrial	
respiration	was	excluded	by	subtracting	point	(9)	from	all	individual	
values.	Basal	respiration	was	calculated	as	an	average	of	point	(1),	(2),	
and	(3).	ADP	absolute	refers	to	point	(4),	proton	leak	refers	to	point	
(5)	and	FCCP	absolute	refers	to	point	(6).	ADP	relative	was	calculated	
as	(4)	divided	by	(3)	*	100%	and	FCCP	relative	was	calculated	as	(6)	
divided	by	(3)	*	100%.	As	a	general	measure	of	overall	mitochondrial	
function,	the	respiratory	control	ratio	(RCR)	was	calculated	as	point	
(4)	divided	by	point	(5)	(Brand	&	Nicholls,	2011).
2.5 | Mitochondrial ATP synthesis—Luciferin‐
luciferase assay
The	rate	of	ATP	synthesis	was	measured	in	the	isolated	mitochon‐
dria	with	an	online	luciferin‐luciferase	coupled	luminescence	assay	
using	a	NOVOstar	microplate	reader	at	28°C	for	optimal	 luciferin‐
luciferase	 response	 (BMG	 Labtech	 GmbH,	 Ortenberg,	 Germany)	
(Jakobsen	 et	 al.,	 2018).	 Mitochondria	 were	 diluted	 in	 respiration	
buffer,	containing	in	mM:	sucrose	250,	K2PO4	15,	MgSO4	2,	EDTA	
0.5	and	0.5%	BSA	 (fatty	acid	 free),	pH	7.2.	10	µl	of	mitochondrial	
suspension	containing	2.5	µg	of	protein	was	added	to	a	clear	bot‐
tom	 96‐well	 plate,	 containing	 the	 respiratory	 substrates:	 10	mM	
pyruvate	 in	 combination	 with	 2	mM	 malate	 or	 10	mM	 succinate	
and	2	µM	rotenone	(all	final	concentrations	and	pH	7.2).	To	inhibit	
adenylate	 cyclase	 activity,	 all	 wells	 also	 contained	 0.2	µM	 P1,P5‐
Di(adenosine‐5′)pentaphosphate	 pentasodium.	 A	 luciferin‐lucif‐
erase	 cocktail	 and	 hexokinase‐purified	 ADP	 (final	 concentration	
0.6	mM)	 was	 added	 to	 each	 well	 and	 luminescence	 was	 assayed	
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for	 36	s	 followed	 by	 injection	 of	 9.62	µM	 ATP	 (final	 concentra‐
tion)	 as	 internal	 standard.	 Each	 condition	 was	 performed	 in	 four	
technical	replicates.	As	a	negative	control,	some	wells	were	added	
2.5	µg/ml	oligomycin	A,	to	inhibit	ATP	synthesis	(data	not	shown).	
Mitochondrial	ATP	synthesis	 is	presented	as	pmol	ATP	produced/
min/µg	protein.	As	a	measure	of	mitochondrial	efficacy,	that	is,	ATP	
production	in	relation	to	O2	consumption,	an	ATP/O2 ratio was cal‐
culated	as	 the	 rate	of	ATP	production	divided	by	 the	ADP‐stimu‐
lated	OCR	determined	by	Seahorse	analyses.
2.6 | Mitochondrial membrane potential—
TMRM assay
To	monitor	the	mitochondrial	membrane	potential	(ΔΨm),	tetrameth‐
ylrhodamine	methyl	ester	 (TMRM)	was	added	 (1	µM,	 final	 concen‐
tration)	to	1	µg	of	regionally	isolated	mitochondria	and	measured	in	
quench	mode	 (530	nm	excitation/590	nm	emission)	 in	a	NOVOstar	
microplate	 reader	 at	 28°C	 (BMG	 Labtech	 GmbH,	 Ortenberg,	
Germany)	(Jakobsen	et	al.,	2018;	Nicholls	&	Ward,	2000).	After	a	sta‐
ble	baseline	was	 reached	 (30	min),	 oligomycin	A	 (5	µg/ml	µM,	 final	
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concentration)	 was	 added	 to	 assess	 the	mitochondrial	 proton	 leak	
(Figure	 1b).	Measurements	 were	 performed	 in	 a	 clear	 bottom	 96‐
well	plate,	in	the	same	respiration	buffer	used	for	the	ATP	synthesis	
assay,	containing	10	mM	pyruvate	in	combination	with	2	mM	malate	
or	10	mM	succinate	and	2	µM	rotenone,	both	conditions	with	0.2	µM	
P1,P5‐Di(adenosine‐5′)pentaphosphate	 pentasodium	 (all	 final	 con‐
centrations	and	pH	7.2).	Traces	of	mitochondrial	membrane	potential	
are	presented	as	ΔΨm(F0/F),	in	which	data	points	were	normalized	to	
the	baseline	levels	obtained	within	the	first	5	min	of	measurements.
2.7 | Study design and handling of data
This	study	was	designed	as	an	exploratory	study	with	no	allocation	
of	subjects	into	experimental	groups,	hence	no	blinding	or	randomi‐
zation	were	 applied.	Data	 shown	 represent	means	±	 standard	de‐
viations	 (unless	other	 is	noted),	with	 individual	data	points	plotted	
as	well.	The	data	are	based	on	six	individual	experiments	(biological	
replicates,	 i.e.,	 from	 individual	 animals),	 except	 for	 the	ATP	meas‐
urements	with	pyruvate/malate	where	only	 four	data	points	were	
obtained	due	to	an	experimental	defect	 in	the	enzymatic	assay.	 In	
some	instances,	negative	values	were	obtained	due	to	methodologi‐
cal	errors.	All	negative	values	were	removed	prior	to	analysis.	If	the	
amount	of	negative	values	exceeded	more	than	half	of	the	technical	
replicates	the	data	point	was	omitted	(one	incidence:	RCR	and	pro‐
ton	leak	with	pyruvate/malate).	Sample	sizes	were	estimated	based	
on	a	pilot	study	and	previous	experiments	 from	which	 it	has	been	
observed	that	the	variability	and	validity	of	data	is	optimal	as	indi‐
cated	by	standard	errors	generally	below	10%	of	the	mean	values.	
Data	were	 inspected	visually	and	 is	assumed	to	follow	normal	dis‐
tribution.	Data	were	analyzed	using	repeated	measures	analysis	of	
variance	 (ANOVA)	 with	 Tukey’s	 post	 hoc	 test	 in	 GraphPad	 Prism	
7. p‐Values	<0.05	was	 considered	 significant	 and	 is	 indicated	with	
a	single	asterisk.	Means,	standard	deviations,	number	of	biological	
replicates	and	all	statistical	analyzes	are	reported	in	Tables	1	and	2.
3  | RESULTS
3.1 | Pyruvate/malate—Complex I‐driven 
respiration and ATP synthesis
Pyruvate	is	the	end‐product	of	glycolysis	and	a	major	mitochondrial	
fuel	 (Sonnewald	et	 al.,	 1998).	To	 investigate	NADH‐linked,	 that	 is,	
complex	 I‐mediated,	 respiration	 and	ATP	 synthesis,	 isolated	mito‐
chondria	 were	 provided	 pyruvate	 and	 malate	 as	 respiratory	 sub‐
strates.	 The	 provided	 malate	 enables	 formation	 of	 oxaloacetate	
needed	 for	 oxidation	 of	 acetylCoA,	 generated	 through	 activity	 of	
pyruvate	dehydrogenase	(PDH),	in	the	TCA	cycle	(Figure	1a).
From	the	basal	 respiration	of	 the	 isolated	mitochondria,	 it	was	
observed	 that	 hippocampal	 mitochondria	 exhibited	 the	 lowest	
OCR	 compared	 to	 the	 cerebral	 cortical	 (F2,10 = 88.17, p	<	0.0001)	
and	 	striatal	 (F2,10 = 88.17, p	<	0.0001)	 mitochondria	 (Figure	 2a).	
Furthermore,	the	OCR	of	cerebral	cortical	mitochondria	was	lower	
than	striatal	mitochondria	(F2,10 = 88.17, p	=	0.0015),	which	had	the	
highest	 basal	OCR.	When	ADP	was	 added,	 it	was	 again	observed	
that	hippocampal	mitochondria	had	a	lower	OCR	when	compared	to	
cerebral	cortical	(F2,10	=	70.03,	p	<	0.0001)	and	striatal	(F2,10	=	70.03,	
F I G U R E  1  Mitochondrial	bioenergetics.	(a)	Mitochondrial	overview.	Mitochondria	are	double	membrane	enclosed	structures,	consisting	
of	an	inner	and	an	outer	membrane,	separating	the	cytosol,	the	intermembrane	space	and	the	mitochondrial	matrix.	In	the	tricarboxylic	
acid	(TCA)	cycle,	located	inside	the	mitochondrial	matrix,	substrates	can	be	oxidized	to	produce	the	reduced	electron	carriers	NADH	and	
FADH2.	In	the	inner	mitochondrial	membrane,	protein	complexes	(designated	I–IV)	are	embedded,	collectively	known	as	the	electron	
transport	chain	(ETC).	Electrons	from	NADH	are	transferred	to	complex	I,	whereas	electrons	from	FADH2	are	transferred	to	complex	II.	The	
enzyme	converting	succinate	to	fumarate,	succinate	dehydrogenase	(SDH),	is	an	integral	part	of	complex	II.	The	flow	of	electrons	through	
the	ETC,	drives	the	expulsion	of	protons	(H+),	through	complex	I,	III,	and	IV,	out	of	the	mitochondrial	matrix	into	the	intermembrane	space,	
creating	a	proton	motive	force.	In	complex	IV,	electrons	are	neutralized	by	O2.	The	proton	gradient,	generated	by	the	ETC,	can	be	utilized	
by	the	ATP	synthase	(complex	V)	to	convert	ADP	into	ATP.	The	entire	process	with	oxidative	metabolism	of	substrates,	ETC	activity,	oxygen	
consumption,	and	ATP	synthesis	is	known	as	oxidative	phosphorylation.	To	investigate	mitochondrial	function	in	isolated	mitochondria,	
pyruvate	in	combination	with	malate	or	succinate	can	be	provided	as	substrates.	Pyruvate	is	converted	into	acetylCoA	by	activity	of	
pyruvate	dehydrogenase	(PDH).	The	provided	malate	will	form	oxaloacetate	needed	to	oxidize	acetylCoA	units	in	the	TCA	cycle.	Since	
most	of	the	reactions	in	the	TCA	cycle	form	NADH,	oxidation	of	pyruvate	in	combination	with	malate,	is	mediated	primarily	via	complex	I.	
Succinate	can	also	be	provided	as	a	metabolic	substrate	and	will	generate	FADH2	directly	for	the	ETC	via	SDH	activity.	Since	oxaloacetate	
is	a	powerful	inhibitor	of	SDH,	it	is	customary	to	add	rotenone,	a	complex	I	inhibitor,	to	the	media,	to	ensure	that	succinate	respiration	is	
not	inhibited	and	only	reflects	complex	II	activity.	In	coupled	mitochondria	it	is	the	level	of	ATP	that	decides	the	activity	of	the	ETC,	that	is,	
there	is	a	coupling	between	ATP	synthesis	and	ETC	activity.	However,	protons	can	also	cross	the	inner	mitochondrial	matrix	independently	
of	complex	V,	which	is	known	as	the	proton	leak.	Certain	compounds	known	as	mitochondrial	uncouplers,	can	greatly	increase	this	flow	
of	protons	into	the	mitochondrial	matrix	bypassing	complex	V,	which	will	induce	uncoupled	respiration.	(b)	Seahorse	coupling	assay.	The	
Seahorse	coupling	assay	can	be	used	to	assess	critical	mitochondrial	parameters	including	coupled	and	uncoupled	oxygen	consumption	
rates	(OCR)	and	proton	leak.	Firstly,	three	basal	measurements	are	performed	(1–3)	in	the	presence	of	the	respiratory	substrates.	ADP	
is	then	added	to	the	mitochondria	which	will	induce	coupled	respiration	by	stimulating	ATP	synthesis	(4).	To	inhibit	coupled	respiration,	
oligomycin	A,	a	complex	V	inhibitor	is	added	to	the	mitochondria	(5).	FCCP	is	a	mitochondrial	uncoupler,	allowing	protons	to	cross	the	inner	
mitochondrial	membrane	and	induce	uncoupled	respiration,	circumventing	complex	V	(6).	Finally,	antimycin	A,	an	inhibitor	of	complex	III,	
is	added	to	assess	non‐mitochondrial	respiration	(7–9).	Arrows	indicate	addition	of	the	respective	compounds.	The	data	shown	are	from	
cerebral	cortical	mitochondria	provided	succinate	(in	the	presence	of	rotenone)	as	respiratory	substrate,	mean	±	standard	deviation,	n = 6
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p	<	0.0001)	mitochondria	(Figure	2b).	Due	to	the	larger	basal	respi‐
ration	of	the	striatal	mitochondria,	a	significant	decrease	in	relative	
OCR,	in	response	to	ADP,	was	observed	when	compared	to	cerebral	
cortical	mitochondria	(F2,10 = 6.729, p	=	0.0118).
Uncoupled	 respiration,	 that	 is,	 respiration	 circumventing	
complex	 V,	 induced	 by	 FCCP	 showed	 no	 significant	 differences	
between	 the	 three	 regions	 (Figure	 2c).	 However,	 the	 hippocam‐
pal	mitochondria	 showed	 the	 greatest	 relative	 increase	 in	OCR	 in	
response	 to	 FCCP	 when	 compared	 to	 mitochondria	 of	 the	 cere‐
bral	 cortex	 (F2,10	=	30.83,	 p	=	0.0006)	 and	 striatum	 (F2,10	=	30.83,	
p	<	0.0001).	To	assess	 the	overall	mitochondrial	 function,	 the	RCR	
was	calculated.	It	was	observed	that	hippocampal	mitochondria	had	
F I G U R E  2  Hippocampal	mitochondria	exhibits	a	lower	metabolic	rate	accompanied	by	a	large	potential	for	uncoupled	respiration	when	
provided	pyruvate	and	malate.	Oxygen	consumption	rates	(OCRs)	and	ATP	synthesis	rates	of	isolated	mitochondria	of	the	mouse	cerebral	
cortex	(open	circles),	hippocampus	(open	squares),	and	striatum	(open	triangles)	with	pyruvate	(10	mM)	and	malate	(2	mM)	as	substrates.	
(a)	Basal	OCR.	(b)	ADP‐stimulated	(coupled)	OCR,	absolute	(left)	and	relative	(right).	(c)	FCCP‐stimulated	(uncoupled)	OCR,	absolute	(left)	
and	relative	(right).	(d)	Respiratory	control	ratio	(RCR).	(e)	Proton	leak.	(f):	Traces	of	mitochondrial	membrane	potential	(means	only).	(g)	ATP	
synthesis	rate.	(h)	ATP/O2	ratio.	Results	are	presented	as	means	±	standard	deviations,	n	=	4–6	obtained	from	individual	animals.	Repeated	
measures	ANOVA,	Tukey’s	post	hoc	test,	*p	<	0.05
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a	 significantly	 reduced	 RCR	 when	 compared	 to	 cerebral	 cortical	
(F2,8	=	53.51,	p	<	0.0001)	 and	 striatal	 (F2,8	=	53.51,	p	<	0.0001)	mi‐
tochondria	(Figure	2d).	This	difference	results	from	a	higher	proton	
leak	of	the	hippocampal	mitochondria,	that	is,	residual	respiration	in	
the	presence	of	the	complex	V	inhibitor	oligomycin	A,	which	was	ob‐
served	when	compared	to	cerebral	cortical	(F2,8	=	20.23,	p	=	0.0023)	
and	striatal	(F2,8	=	20.23,	p	=	0.0010)	mitochondria	(Figure	2e).	The	
elevated	hippocampal	proton	 leak	was	 furthermore	validated	by	a	
lower	membrane	potential	of	hippocampal	mitochondria	in	the	pres‐
ence	of	oligomycin	A,	when	compared	to	cerebral	cortical	and	stria‐
tal	mitochondria	(Figure	2f).
No	changes	were	found	in	the	ATP	production	rate	of	the	three	
regions	(Figure	2g).	To	further	evaluate	the	mitochondrial	efficiency	
of	substrate	oxidation,	that	is,	how	much	ATP	is	produced	relative	to	
oxygen	consumption,	a	ratio	between	ATP	production	and	oxygen	
consumption	was	calculated	(Figure	2h).	Here,	it	was	observed	that	
striatal	mitochondria	exhibited	a	slightly	reduced	ATP/O2	ratio	when	
compared	to	hippocampal	mitochondria	(F2,6 = 5.749, p	=	0.0342).
3.2 | Succinate—Complex II‐driven respiration and 
ATP synthesis
Complex	II‐driven	respiration	and	ATP	synthesis	can	be	assessed	by	
providing	the	mitochondria	with	succinate	as	respiratory	substrate.	
Succinate	is	converted	into	fumarate	by	activity	of	succinate	dehy‐
drogenase	 (SDH),	 which	 is	 part	 of	 complex	 II	 and	 hereby	 directly	
provide	 FADH2	 to	 the	 ETC	 (Figure	 1a).	 To	 ensure	 that	 succinate	
oxidation	 reflects	complex	 II,	 that	 is,	FADH2‐mediated	 respiration,	
the	 complex	 I	 inhibitor	 rotenone	 was	 included	 in	 the	 respiration	
buffer.	 Rotenone	 inhibits	 the	 oxidation	 of	NADH	 to	NAD+,	which	
will	block	the	conversion	of	malate	to	oxaloacetate	as	this	reaction	
reduces	NAD+	to	NADH	(Figure	1a).	Since	oxaloacetate	is	a	powerful	
inhibitor	of	SDH,	the	addition	of	 rotenone	will	 increase	the	oxida‐
tion	of	succinate	(Papa,	Lofrumento,	Paradies,	&	Quagliariello,	1969;	
Wojtczak,	Wojtczak,	&	Ernster,	1969).
When	 the	 regionally	 isolated	mitochondria	were	provided	suc‐
cinate,	 it	 was	 observed	 that	 striatal	mitochondria	 exhibited	 a	 sig‐
nificantly	 increased	 basal	 OCR	 in	 comparison	 to	 both	 cerebral	
cortical	 (F2,10	=	23.42,	 p	=	0.0015)	 and	 hippocampal	 (F2,10	=	23.42,	
p	=	0.0002)	mitochondria	 (Figure	 3a).	 ADP	 stimulation	 also	 led	 to	
the	largest	increase	in	absolute	OCR	in	striatal	mitochondria	when	
compared	 to	 mitochondria	 of	 the	 cerebral	 cortex	 (F2,10	=	30.63,	
p	=	0.0029)	and	hippocampus	(F2,10	=	30.63,	p	<	0.0001)	(Figure	3b).	
Furthermore,	the	hippocampal	mitochondria	exhibited	a	decreased	
OCR	when	compared	to	cerebral	cortical	mitochondria	(F2,10	=	30.63,	
p	=	0.0204).	 The	 differences	 in	 relative	 OCR	 upon	 ADP	 stimula‐
tion	were	of	a	much	smaller	magnitude.	However,	 it	was	observed	
that	 the	 relative	OCR	of	 the	hippocampal	mitochondria	again	was	
decreased	when	compared	 to	mitochondria	of	 the	cerebral	 cortex	
(F2,10 = 12.80, p	=	0.0058)	and	striatum	(F2,10 = 12.80, p	=	0.0024).
When	 challenged	 with	 FCCP,	 mitochondria	 of	 the	 stria‐
tum	 showed	 an	 elevated	 OCR	 when	 compared	 to	 cerebral	 cor‐
tical	 (F2,10	=	38.64,	 p	=	0.0065)	 and	 hippocampal	 (F2,10	=	38.64,	
p	<	0.0001)	mitochondria,	and	the	OCR	of	hippocampal	mitochondria	
were	furthermore	decreased	when	compared	to	cerebral	cortical	mi‐
tochondria	(F2,10	=	38.64,	p	=	0.0020)	(Figure	3c).	The	relative	OCR,	
during	FCCP	stimulation,	showed	that	the	OCR	of	hippocampal	mito‐
chondria	was	significantly	smaller	when	compared	to	mitochondria	
of	the	cerebral	cortex	(F2,10 = 8.048, p	=	0.0070)	and	the	same	trend	
was	present	when	compared	to	striatal	mitochondria	(F2,10 = 8.048, 
p	=	0.0630).	As	observed	 for	 the	pyruvate/malate	condition,	mito‐
chondria	of	the	hippocampus	had	a	significantly	reduced	RCR	when	
compared	to	cerebral	cortical	(F2,10 = 45.68, p	=	0.0001)	and	striatal	
(F2,10 = 45.68, p	<	0.0001)	mitochondria	(Figure	3d).	The	decreased	
RCR	was	again	mediated	by	an	increased	hippocampal	proton	leak,	
which	was	higher	when	compared	to	cerebral	cortical	mitochondria	
(F2,10 = 7.196, p	=	0.0094),	but	not	striatal	mitochondria	(Figure	3e).	
However,	from	measurements	of	the	mitochondrial	membrane	po‐
tential,	it	was	observed	that	hippocampal	mitochondria	exhibited	a	
lower	membrane	potential	in	the	presence	of	oligomycin	A,	indica‐
tive	of	an	elevated	proton	leak,	when	compared	to	both	mitochon‐
dria	of	the	cerebral	cortex	and	striatum	(Figure	3f).
Hippocampal	 mitochondria	 had	 the	 lowest	 rate	 of	 ATP	 pro‐
duction	 compared	 to	 cerebral	 cortical	 (F2,10 = 24.56, p	=	0.0009)	
and	 striatal	 (F2,10 = 24.56, p	=	0.0002)	 mitochondria	 (Figure	 3g).	
However,	the	ATP	production	was	balanced	by	oxygen	consumption,	
signified	by	equal	ATP/O2	ratios	for	all	regions	(Figure	3h).
4  | DISCUSSION
Here,	we	investigated	the	rates	of	oxygen	consumption	and	ATP	syn‐
thesis,	 in	 isolated	mitochondria	of	 the	mouse	cerebral	cortex,	hip‐
pocampus,	and	striatum	using	different	respiratory	substrates.	We	
provide	functional	evidence	of	heterogeneity	in	mitochondrial	ener‐
getics	between	the	three	brain	regions	investigated.	When	pyruvate	
and	malate	were	provided	as	substrates,	hippocampal	mitochondria	
exhibited	the	lowest	basal	and	coupled	OCR,	however,	with	compa‐
rable	efficiency	of	ATP	synthesis	to	the	other	regions.	Hippocampal	
mitochondria	also	exhibited	a	larger	proton	leak	and	elevated	rela‐
tive	OCR	in	response	to	FCCP,	showing	a	large	capacity	for	uncou‐
pled	 respiration.	 When	 the	 complex	 II‐linked	 substrate	 succinate	
was	provided,	striatal	mitochondria	exhibited	the	highest	respiration	
and	ATP	synthesis	rate,	whereas	hippocampal	mitochondria	had	the	
lowest.	However,	equal	ATP/O2	ratios	between	the	regions	suggests	
similar	mitochondrial	efficiency	of	succinate	oxidation.
4.1 | Mitochondrial isolation and function
In	 this	 report,	 cerebral	mitochondria	were	 isolated	using	 a	Percoll	
density	gradient,	allowing	separation	of	non‐synaptic	mitochondria	
from	other	cellular	components,	including	myelin	and	cellular	debris,	
but	also	unwanted	metabolic	active	entities	such	as	synaptosomes	
(Chinopoulos	 et	 al.,	 2011;	 Sims,	 1990).	 Isolation	 of	 mitochondria	
allows	 tight	 experimental	 control	 and	 the	possibility	of	direct	ma‐
nipulation,	but	may	compromise	other	physiological	factors,	such	as	
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structure,	intra‐cellular	connections,	and	signaling	pathways	(Brand	
&	Nicholls,	2011;	Picard,	Taivassalo,	Gouspillou,	&	Hepple,	2011).	To	
assess	the	integrity	of	isolated	mitochondria,	the	RCR	is	a	commonly	
applied	relative	measure	that	describes	overall	mitochondrial	func‐
tion	(Brand	&	Nicholls,	2011).	We	obtained	RCRs	values	in	the	range	
of	3–7	with	pyruvate/malate	 and	2–4	with	 succinate	 as	 substrate.	
Compared	 to	 the	 literature,	 these	 values	 signify	 well‐functioning	
mitochondria,	 validating	 the	quality	of	our	preparation	 (Burtscher,	
Zangrandi,	 Schwarzer,	&	Gnaiger,	 2015;	Cardoso,	 Santos,	 Seica,	&	
Moreira,	2010;	Czerniczyniec	et	 al.,	2015;	Dagani	et	 al.,	1988;	Lai	
et	al.,	1977;	Sauerbeck	et	al.,	2011;	Sims,	1990;	Varela,	Schwartz,	&	
Horvath,	2016).	We	observed	that	hippocampal	mitochondria	exhib‐
ited	a	larger	proton	leak,	with	both	substrate	conditions,	resulting	in	
reduced	RCR	values	for	this	region.	This	is	an	important	notion,	as	
F I G U R E  3  Striatal	mitochondria	display	elevated	basal	and	stimulated	oxygen	consumption	when	provided	succinate	as	respiratory	
substrate.	Isolated	mitochondria	from	mouse	cerebral	cortex	(open	circles),	hippocampus	(open	squares),	and	striatum	(open	triangles)	were	
provided	succinate	(10	mM),	in	the	presence	of	the	complex	I	inhibitor	rotenone	(2	µM),	as	respiratory	substrate.	(a)	Basal	OCR.	(b)	ADP‐
stimulated	(coupled)	OCR,	absolute	(left)	and	relative	(right).	(c)	FCCP‐stimulated	(uncoupled)	OCR,	absolute	(left)	and	relative	(right).	(d)	
Respiratory	control	ratio	(RCR).	(e)	Proton	leak.	(f)	Traces	of	mitochondrial	membrane	potential	(means	only).	(g)	ATP	synthesis	rate.	(h)	ATP/
O2	ratio.	Results	are	presented	as	means	±	standard	deviations,	n	=	6	obtained	from	individual	animals.	Repeated	measures	ANOVA,	Tukey’s	
post	hoc	test,	*	p	<	0.05
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the	choice	of	substrate	should	not	alter	the	RCR	(Brand	&	Nicholls,	
2011).	However,	since	succinate	oxidation	does	not	contribute	to	the	
generation	of	the	proton	motive	force	through	complex	I	of	the	ETC,	
the	RCR	values	often	tends	to	be	lower	when	compared	to	NADH‐
linked	 substrates,	 which	 was	 also	 the	 case	 in	 the	 present	 study	
(Brand	&	Nicholls,	2011).	The	isolation	technique	used	for	this	study	
yields	non‐synaptic	mitochondria	originating	from	both	neurons	and	
glial	cells.	The	Percoll	isolation	yields	a	mitochondrial	fraction	with	
a	high	purity	(Chinopoulos	et	al.,	2011;	Sims,	1990),	however,	some	
contamination	of	membrane	proteins	and	synaptosomes	will	still	be	
present.	It	should	therefore	be	noted	that	the	isolated	mitochondrial	
fractions	are	derived	from	heterogeneous	cellular	populations	and	
might	exhibit	different	degrees	of	contamination,	which	potentially	
could	have	influenced	the	results.
4.2 | Regional differences in mitochondrial OCR and 
ATP synthesis rate
Only	 few	other	studies,	using	Seahorse	 technology	to	assess	mito‐
chondrial	 function	 in	 regionally	 isolated	 brain	 mitochondria,	 have	
been	performed.	A	study	by	Sauerbeck	et	al.	showed	that	mitochon‐
dria	 isolated	 from	 the	 rat	 cerebral	 cortex,	 hippocampus,	 and	 stria‐
tum	 exhibited	 equal	 coupled	OCRs	with	 pyruvate/malate,	 and	 the	
same	uncoupled	OCRs	with	 succinate	 in	 the	presence	of	 rotenone	
(Sauerbeck	 et	 al.,	 2011).	 Interestingly,	 the	 authors	 also	 reported	 a	
trend	toward	a	larger	residual	respiration	in	the	presence	of	oligomy‐
cin	A,	that	is,	proton	leak,	of	striatal	and	hippocampal	mitochondria	
(Sauerbeck	et	al.,	2011).	Here,	we	observed	an	increased	proton	leak	
in	isolated	hippocampal	mitochondria	of	the	mouse	brain,	however,	
this	was	 not	 the	 case	 in	 the	 striatal	mitochondria.	 Another	 recent	
study,	likewise	performed	in	rats,	showed	that	regional	mitochondrial	
function	fluctuates	with	age	(Pandya,	Royland,	MacPhail,	Sullivan,	&	
Kodavanti,	2016).	The	authors	reported	that	cerebral	cortical,	striatal,	
and	hippocampal	mitochondria,	 isolated	 from	young	rats,	exhibited	
comparable	bioenergetics	profiles,	however,	particularly	hippocam‐
pal	mitochondrial	function	declined	with	increasing	age	(Pandya	et	al.,	
2016).	A	relevant	extension	of	this	study	could	include	assessment	of	
how	regional	mitochondrial	function	in	mice	is	related	to	age.
We	found	that	mitochondria	of	the	hippocampus,	generally	con‐
sumed	oxygen	and	synthesized	ATP	at	lower	rates,	when	compared	
to	mitochondria	of	the	other	two	regions.	These	observations	of	low	
hippocampal	oxygen	consumption	is	in	line	with	several	other	reports	
of	isolated	mitochondria	(Burtscher	et	al.,	2015;	Cardoso	et	al.,	2010;	
Czerniczyniec	et	al.,	2015;	Dagani	et	al.,	1988;	Sims,	1990;	Varela	et	
al.,	2016)	and	brain	homogenates	(Sims,	Finegan,	&	Blass,	1986;	Sims	
&	Pulsinelli,	1987).	However,	it	was	also	observed	that	hippocampal	
mitochondria	 exhibited	 comparable	ATP/O2	 ratios	 to	 the	 other	 re‐
gions,	 suggesting	an	overall	 general	 lower	mitochondrial	 activity	 in	
this	region	(Dagani	et	al.,	1988).	A	striking	finding	of	this	study	is	the	
hippocampal	capacity	of	uncoupled	respiration	when	provided	pyru‐
vate	and	malate.	Even	though	both	the	basal	and	ADP‐induced	OCR	
of	the	hippocampal	mitochondria	were	lower,	the	absolute	uncoupled	
respiration	was	 equal	 across	 the	 regions,	 leading	 to	 a	much	 larger	
relative	OCR	increase.	This	elevated	hippocampal	uncoupling	capac‐
ity	has	also	been	observed	in	hippocampal	synaptosomes	fueled	by	
glucose	 (Lee	 et	 al.,	 2013),	 and	 shows	 that	 hippocampal	mitochon‐
dria	 possess	 the	 same	 capacity	 for	maximal	 uncoupled	 respiration	
as	the	other	regions,	which	is	not	active	during	coupled	respiration.	
We	also	observed	that	the	RCR	of	hippocampal	mitochondria	were	
significantly	 lower	when	compared	 to	 the	other	 regions,	due	 to	an	
elevated	proton	leak	across	the	inner	mitochondrial	membrane.	The	
proton	 leak	constitute	a	 large	 fraction	of	 the	 resting	mitochondrial	
metabolic	 rate	 but	 the	mechanisms	 and	 functions	 are	 still	 unclear	
(Jastroch,	Divakaruni,	Mookerjee,	Treberg,	&	Brand,	2010).	The	pro‐
ton	 leak	 is	 affected	 by	 the	 mitochondrial	 membrane	 composition,	
including	fatty	acid	composition	and	expression	of	transporters	and	
proteins	 (Brand,	Chien,	Ainscow,	Rolfe,	&	Porter,	1994;	 Jastroch	et	
al.,	2010;	Stuart,	Cadenas,	Jekabsons,	Roussel,	&	Brand,	2001).	One	
group	 of	 proteins,	 the	 uncoupling	 proteins	 (UCPs),	 allows	 protons	
to	cross	the	 inner	mitochondrial	membrane	and	are	 involved	 in	the	
proton	leak	(Jastroch	et	al.,	2010).	The	functions	of	the	UCPs	in	the	
brain	are	still	unclear,	but	they	influence	mitochondrial	function,	cal‐
cium	handling,	and	production	of	reactive	oxygen	species	(Andrews,	
Diano,	&	Horvath,	2005).	Further	studies	have	to	reveal	if	UCPs	could	
be	linked	to	the	observed	differences	in	hippocampal	mitochondrial	
function	and	possibly	neurodegenerative	diseases.
Mitochondria	 isolated	 from	 the	 striatum	 exhibited	 the	 largest	
basal	 OCR,	 when	 provided	 both	 pyruvate/malate	 and	 succinate.	
Furthermore,	the	absolute	OCR	of	striatal	mitochondria,	when	pro‐
vided	succinate,	was	larger	than	mitochondria	of	the	cerebral	cortex,	
which	was	not	 the	case	when	using	pyruvate	and	malate	as	 respi‐
ratory	 substrates.	 Several	 recent	 studies	have	 reported	elevations	
in	both	coupled	and	uncoupled	OCRs	of	striatal	mitochondria	when	
provided	 succinate	 as	 substrate,	 which	 is	 in	 line	 with	 our	 results	
(Burtscher	et	al.,	2015;	Pandya	et	al.,	2016;	Subramaniam,	Vergnes,	
Franich,	 Reue,	 &	 Chesselet,	 2014).	 A	 general	 hypothesis	 on	 the	
pathogenesis	of	Huntington’s	disease,	a	disease	primarily	affecting	
the	striatum,	is	that	the	mitochondria	of	the	striatum	are	more	sen‐
sitive	to	metabolic	insults	and	therefore	more	susceptible	to	neuro‐
degeneration	 (Browne	&	Beal,	 2004;	Damiano,	Galvan,	Deglon,	&	
Brouillet,	2010;	Mochel	&	Haller,	2011).	Interestingly,	systemic	injec‐
tions	with	the	SDH	inhibitor,	3‐nitropropionic	acid,	leads	to	selective	
lesions	in	the	striatum,	suggesting	that	striatal	mitochondria	are	vul‐
nerable	to	inhibition	of	SDH	(Beal	et	al.,	1993;	Brouillet	et	al.,	1995).	
Our	results	of	elevated	basal	respiration	and	increased	capacity	of	
succinate	oxidation	of	striatal	mitochondria	are	in	line	with	this	and	
support	that	SDH	impairments	may	be	a	sensitive	target	of	neurode‐
generation	in	the	striatum.
4.3 | Complex I‐ and II‐mediated OCR and ATP 
synthesis rate
When	 comparing	 the	 applied	 respiratory	 substrate	 conditions,	
pyruvate/malate	 versus	 succinate,	 reflecting	 complex	 I	 and	 com‐
plex	 II‐linked	 respiration,	 respectively,	 the	 absolute	 differences	
in	OCRs	 are	 striking.	 The	OCRs	were	 found	 to	 be	 approximately	
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fourfold	higher	 for	 succinate	when	 compared	 to	pyruvate/malate	
for	all	regions.	This	observation	is	in	accordance	with	previous	re‐
ports	(Clark	&	Nicklas,	1970;	Iuso	et	al.,	2017;	Rogers	et	al.,	2011),	
and	is	explained	by	succinate	providing	electrons	for	the	ETC	with	
only	one	enzymatic	reaction	through	SDH	with	subsequent	FADH2 
generation.	Pyruvate,	on	the	other	hand,	must	undergo	several	con‐
secutive	enzymatic	 steps	 in	order	 to	provide	NADH	 for	 the	ETC.	
However,	 the	 ATP	 synthesis	 rate	was	 not	 increased	 to	 the	 same	
extent	as	the	OCR,	which	became	apparent	by	the	ATP/O2 ratios, 
which	 were	 threefold	 reduced	 for	 succinate	 when	 compared	 to	
pyruvate/malate.	This	notion	is	in	line	with	the	classic	phosphate/
oxygen	(P/O	or	ADP/O)	ratios,	describing	how	many	moles	ATP	are	
synthesized/0.5	moles	O2	consumed	(Hinkle	&	Yu,	1979).	The	stand‐
ard	P/O	ratios	are	estimated	to	be	2.5	for	NADH‐linked	substrates	
(such	as	pyruvate	in	combination	with	malate)	and	1.5	for	succinate	
(Hinkle,	2005;	Hinkle	&	Yu,	1979).	We	found	that	oxidative	phos‐
phorylation	on	pyruvate/malate	in	combination	were	roughly	three	
times	more	efficient	than	succinate,	when	OCRs	were	compared	to	
the	rates	of	ATP	synthesis.	This	result	might	seem	excessive	when	
compared	to	the	established	P/O	ratios,	however,	our	calculations	
are	based	on	the	combination	of	two	different	assays,	making	the	
direct	 comparison	 difficult	 as	 the	 experimental	 prerequisites	 are	
different.
4.4 | Conclusions
This	 study	 reveals	 clear	 differences	 in	 OCR	 and	 ATP	 synthesis	
rates,	mediated	 through	 complex	 I	 and	 complex	 II	 of	 the	ETC,	 in	
isolated	mitochondria	from	cerebral	cortex,	hippocampus,	and	stri‐
atum	of	the	mouse	brain.	We	found	that	mitochondrial	efficiency,	
that	is,	ATP	synthesis/O2	consumed,	was	comparable	between	the	
three	regions.	Hippocampal	mitochondria	exhibited	a	larger	proton	
leak,	 whereas	 striatal	 mitochondria	 had	 an	 elevated	 basal	 respi‐
ration	 and	 increased	 capacity	 for	 succinate	 oxidation.	 This	 study	
underlines	the	importance	of	investigating	cerebral	mitochondrial	
function	 regionally,	 as	 regional	 differences	may	by	masked	when	
multiple	 regions	 are	 pooled.	 Furthermore,	 we	 advocate	 to	 asses	
OCR	 in	combination	with	ATP	synthesis	 rate,	as	either	one	alone	
can be misleading.
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